Skip to content

Effect of Gerofit Exercise on Cognition in Older Veterans

Relationship of Exercise Frequency, Intensity, and Fitness to Improved Cognition and Biomarkers in Gerofit Participants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06107842
Enrollment
150
Registered
2023-10-30
Start date
2024-04-01
Completion date
2029-03-31
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cognitive Impairment, Physical Activity

Brief summary

Over 50% of the Veterans enrolled for VA health care are over the age of 65. Dementia prevalence increases with age, and with the increase in the population of people ages 65 and older, the total number of people with dementia is also increasing. Older Veterans often have comorbid PTSD, major depression and traumatic brain injury so that they are at 2 to 5 times the risk for cognitive impairment and dementia compared to the general population. There is evidence that exercise interventions in sedentary older adults could improve both physical and cognitive function. However, there have been very few studies on the effects of exercise on cognition in older Veterans and do not reflect the broader ethnic and health-status diversity of Veterans. Thus, improved knowledge of the role of exercise on cognition as well as the predictive power of biomarkers could have a major beneficial impact on Veterans' functional independence and quality of life. The investigators hypothesize that participation in the VA Gerofit exercise program will improve cognitive function in older Veterans and that blood and muscle biomarkers will predict these improvements.

Interventions

BEHAVIORALGerofit exercise

Individualized exercise prescription as well as a group exercise class based on physical function assessments offered 3x/week

BEHAVIORALHealth education

Scheduled monthly in-person health education discussion sessions covering 12 different health topics not including a physical activity/exercise promotion session

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Gerofit intervention vs Health Education Control

Intervention model description

randomized controlled study

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All Veterans eligible for VA Gerofit program 65 years and older * Clearance by PCP to participate in Gerofit exercise program

Exclusion criteria

* Inability to perform ADLs * Significant cognitive impairment * Inability to function independently without assistance * Unstable angina; proliferative diabetic retinopathy * Oxygen dependent * Unwillingly to commute and/or not able to provide own transportation to Gerofit * Incontinence * Open wounds * Volatile behavioral issue or unable to work successfully in a group environment/setting * Active substance abuse * Homelessness

Design outcomes

Primary

MeasureTime frameDescription
Memory composite scoreChange from baseline at 3 monthsHVLT-R, verbal memory and BVMT-R, visual memory
Executive Function composite scoreChange from baseline at 3 monthsStroop C, Trails B, Digit span backwards and sequencing from WAIS-IV, verbal fluency, FAS and animals
Total BDNFChange from baseline at 3 monthsTotal brain derived neurotrophic factor (BDNF) concentrations in serum
Mature BDNFChange from baseline at 3 monthsMature brain derived neurotrophic factor (BDNF) concentrations in serum

Countries

United States

Contacts

CONTACTCathy C Lee, MD
cathy.lee2@va.gov(310) 268-4110
PRINCIPAL_INVESTIGATORCathy C Lee, MD

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

PRINCIPAL_INVESTIGATORJonathan M Wanagat, MD PhD

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

PRINCIPAL_INVESTIGATORStacy Wilkins, PhD

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026